Da mesma revista
Intermittent doxercalciferol (1 alpha-hydroxyvitamin D-2) therapy for secondary hyperparathyroidism (2000)
Artigo em Revista Científica Internacional
João Frazão; Elangovan, L; Maung, HM; Chesney, RW; Acchiardo, SR; Bower, JD; Kelley, BJ; Rodriguez, HJ; Norris, KC; Robertson, JA; Levine, BS; Goodman, WG; Gentile, D; Mazess, RB; Kyllo, DM; Douglass, LL; Bishop, CW; Coburn, JW
Estimated GFR and the Effect of Intensive Blood Pressure Lowering after Acute Intracerebral Hemorrhage (2016)
Artigo em Revista Científica Internacional
Zheng, D; Sato, S; Arima, H; Heeley, E; Delcourt, C; Cao, Y; Chalmers, J; Anderson, CS; Anderson, C; Chalmers, J; Arima, H; Davis, S; Heeley, E; Huang, Y; Lavados, P; Neal, B; Parsons, M; Lindley, R; Morgenstern, L; Robinson, T...(mais 739 autores)
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1 alpha-hydroxyvitamin D-2) in dialysis patients with secondary hyperparathyroidism: A sequential comparison (2001)
Artigo em Revista Científica Internacional
Maung, HM; Elangovan, L; João Frazão; Bower, JD; Kelley, BJ; Acchiardo, SR; Rodriguez, HJ; Norris, KC; Sigala, JF; Rutkowski, M; Robertson, JA; Goodman, WG; Levine, BS; Chesney, RW; Mazess, RB; Kyllo, DM; Douglass, LL; Bishop, CW; Coburn, JW
Ver todas (6)